|
C15ORF38 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.28879999794896E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.49850000003205E-06 |
| Normal-vs-Stage2 |
2.464200E-02 |
| Normal-vs-Stage3 |
1.355580E-04 |
| Normal-vs-Stage4 |
8.36190000000903E-05 |
| Stage1-vs-Stage2 |
9.912600E-01 |
| Stage1-vs-Stage3 |
3.012600E-01 |
| Stage1-vs-Stage4 |
2.056300E-02 |
| Stage2-vs-Stage3 |
4.154400E-01 |
| Stage2-vs-Stage4 |
3.253700E-02 |
| Stage3-vs-Stage4 |
7.840500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.47700000019802E-07 |
| Normal-vs-AfricanAmerican |
1.05779999981515E-07 |
| Normal-vs-Asian |
7.03910000288133E-08 |
| Caucasian-vs-AfricanAmerican |
3.330600E-01 |
| Caucasian-vs-Asian |
7.050400E-02 |
| AfricanAmerican-vs-Asian |
2.598100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.51060000250925E-10 |
| Normal-vs-Female |
7.555900E-02 |
| Male-vs-Female |
9.701600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.215100E-04 |
| Normal-vs-Extreme_Weight |
3.58620000362464E-09 |
| Normal-vs-Obese |
4.567500E-04 |
| Normal-vs-Extreme_Obese |
1.361310E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.115000E-01 |
| Normal_Weight-vs-Obese |
5.579800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.398600E-01 |
| Extreme_Weight-vs-Obese |
1.001400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.417400E-01 |
| Obese-vs-Extreme_Obese |
1.756040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.720200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.421090E-04 |
| Normal-vs-Age(61-80Yrs) |
3.56930000000588E-08 |
| Normal-vs-Age(81-100Yrs) |
1.597760E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.868600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.319400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.164000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.118200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.001400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.533800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.07650000030968E-07 |
| Normal-VS-Type2 PRCC |
2.93699999998065E-06 |
| Normal-VS-KIRP CIMP |
4.057700E-03 |
| Normal-VS-Unclassified PRCC |
4.832000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.843600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.769550E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.739700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.190200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.970190E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.009600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.71630000398582E-08 |
| Normal-vs-N1 |
5.5217999999968E-05 |
| Normal-vs-N2 |
6.130300E-02 |
| N0-vs-N1 |
6.949400E-01 |
| N0-vs-N2 |
3.382200E-01 |
| N1-vs-N2 |
4.671600E-01 |
|
|
